NCT03040297 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Blanch LL
Clinical studies of tracheal gas insufflation. Respir Care. 2001 Feb;46(2):158-66. Review.
Durbin CG Jr
Tracheostomy: why, when, and how? Respir Care. 2010 Aug;55(8):1056-68. Review.
Hess DR, Gillette MA
Tracheal gas insufflation and related techniques to introduce gas flow into the trachea. Respir Care. 2001 Feb;46(2):119-29. Review.
Hoffman LA, Tasota FJ, Delgado E, Zullo TG, Pinsky MR
Effect of tracheal gas insufflation during weaning from prolonged mechanical ventilation: a preliminary study. Am J Crit Care. 2003 Jan;12(1):31-9.
Kacmarek RM
Complications of tracheal gas insufflation. Respir Care. 2001 Feb;46(2):167-76. Review.
Knebel AR
When weaning from mechanical ventilation fails. Am J Crit Care. 1992 Nov;1(3):19-29; quiz 30-1. Review.
Nahum A
Animal and lung model studies of tracheal gas insufflation. Respir Care. 2001 Feb;46(2):149-57. Review.

Effect of Parallel Oxygen Delivery Through a Tracheal Gas Insufflation (TGI) and a T-piece on Blood Gases and Respiratory Rate in ICU Tracheostomized Patients as an Extra Supporting Method During Weaning From Mechanical Ventilation.

Details for clinical trial NCT03040297

Clinical trial NCT03040297 - References